🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
This clinical trial examines an investigational scan (64Cu-DOTA-trastuzumab...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2022-12-21
Trial ID
NCT05376878
Previously untreated patients with limited metastatic stage (see protocol f...
Status
Completed
Location
Krankenhaus Nordwest
Start Date
2016-02
Trial ID
NCT02578368
Treatments Being Tested
Multiple trials confirm systemic T-DXd efficacy in HER2+ breast cancer with...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-18
Trial ID
NCT07134153
Treatments Being Tested
This is a Phase II, randomized, multicentre, multinational, open-label, cro...
Status
Completed
Location
Rocky Mountain Cancer Center - Lakewood (West)
Start Date
2018-12-19
Trial ID
NCT03674112
Breast cancer is the most common malignant tumor in women. EC-TH is one of ...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2019-01-10
Trial ID
NCT04172259
StrataPATH™ is a non-randomized, open-label trial designed to explore effic...
Status
Terminated
Location
Florida Cancer Specialists - North
Start Date
2022-04-29
Trial ID
NCT05097599
Trastuzumab plus chemotherapy is an effective therapy in HER2 positive adva...
Status
Completed
Location
Zhongshan Hospital Affiliated to Fudan University
Start Date
2012-01
Trial ID
NCT03024450
Treatments Being Tested
Multi-center, open-label, randomized trial of patients with low-risk, HER2+...
Status
Completed
Location
London Health Sciences Centre
Start Date
2019-05-01
Trial ID
NCT03705429
Treatments Being Tested
Breast cancer is an optimal "model disease" for studying personalized medic...
Status
Active Not Recruiting
Location
Akershus University Hospital
Start Date
2016-04-15
Trial ID
NCT02624973
Treatments Being Tested